Comprehensive transcriptomic analysis and meta-analysis identify therapeutic effects of N-acetylcysteine in nonalcoholic fatty liver disease
Yang K, Kim H, Shim Y, Ryu T, Kim C. Comprehensive transcriptomic analysis and meta-analysis identify therapeutic effects of N-acetylcysteine in nonalcoholic fatty liver disease. Frontiers In Pharmacology 2023, 14: 1186582. PMID: 37256235, PMCID: PMC10225598, DOI: 10.3389/fphar.2023.1186582.Peer-Reviewed Original ResearchNonalcoholic fatty liver diseaseEffect of N-acetylcysteineN-acetylcysteineFatty liver diseaseLiver diseaseEfficacy of N-acetylcysteineProtective effect of N-acetylcysteineTherapeutic potentialPrevalence of nonalcoholic fatty liver diseaseTherapeutic effect of N-acetylcysteineMeta-analysisLevels compared to controlsN-acetylcysteine treatmentAssociated with NAFLD developmentSystematic Review CentrePreclinical studiesClinical trialsLiver injuryWeb of ScienceGlucose intoleranceTherapeutic effectGlobal health issueCochrane LibraryEgger's testHepatic steatosis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply